Published in Ann Intern Med on October 01, 1996
Harvard Atherosclerosis Reversibility Project (HARP) | NCT00000461
Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver. Lipids Health Dis (2009) 0.82
Hypolipidemic drugs in coronary artery disease. Ann Intern Med (1997) 0.75
Hypolipidemic drugs in coronary artery disease. Ann Intern Med (1997) 0.75
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med (2001) 9.31
Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology (1997) 7.81
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med (1991) 6.13
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA (2000) 6.00
Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr (1999) 5.12
Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med (1985) 5.09
Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA (1994) 4.64
Circadian variation and triggers of onset of acute cardiovascular disease. Circulation (1989) 4.48
Circadian variation in the frequency of sudden cardiac death. Circulation (1987) 3.98
B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med (2000) 3.89
A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA (1996) 3.69
Unstable angina pectoris. N Engl J Med (2000) 3.58
Depression, heart rate variability, and acute myocardial infarction. Circulation (2001) 3.57
Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med (2001) 3.56
A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes. EMBO J (1998) 3.27
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet (2009) 3.13
Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr (2001) 3.12
Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity (2000) 3.07
Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus. Virology (1982) 2.78
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med (1991) 2.68
Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst (1994) 2.68
Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol (1992) 2.68
Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med (1993) 2.55
Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. J Am Coll Cardiol (1995) 2.52
Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med (1997) 2.48
Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med (1990) 2.37
Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res (1999) 2.30
Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet (1989) 2.28
Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH. Virology (1983) 2.27
Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol (1987) 2.27
The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr (1998) 2.24
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med (1998) 2.22
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. Ann Intern Med (1980) 2.19
Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients. Am J Cardiol (1983) 2.18
Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst (1993) 2.15
The identification of rofA, a positive-acting regulatory component of prtF expression: use of an m gamma delta-based shuttle mutagenesis strategy in Streptococcus pyogenes. Mol Microbiol (1994) 2.14
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects. Ann Intern Med (1980) 2.08
Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation (2000) 2.01
No foot in the door: an experimental study of employment discrimination against older workers. J Aging Soc Policy (1999) 2.01
Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol (1987) 2.01
Atrial ejection force: a noninvasive assessment of atrial systolic function. J Am Coll Cardiol (1993) 1.99
Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation (1994) 1.98
Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study. N Engl J Med (1986) 1.96
Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab (1997) 1.88
Cardiovascular disease in women. Circulation (1993) 1.87
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation (1999) 1.83
Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women. Am J Clin Nutr (1991) 1.78
Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol (2001) 1.77
Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA (2001) 1.75
A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA (1999) 1.74
Electrocardiographic diagnosis of myocardial infarction in the presence of complete left bundle branch block. Am Heart J (1988) 1.69
Analysis of possible triggers of acute myocardial infarction (the MILIS study). Am J Cardiol (1990) 1.68
Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. J Am Coll Cardiol (1998) 1.68
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol (1998) 1.67
Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS) Circulation (1993) 1.66
First steps toward understanding the pathophysiologic link between air pollution and cardiac mortality. Am Heart J (1999) 1.65
Comparison of long-term outcome after acute myocardial infarction in patients never graduated from high school with that in more educated patients. Multicenter Investigation of the Limitation of Infarct Size (MILIS). Am J Cardiol (1993) 1.63
Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med (1980) 1.62
Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. Am Heart J (1989) 1.62
Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions. J Am Coll Cardiol (1998) 1.61
Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol (1994) 1.61
Intravascular hemodynamic factors responsible for progression of coronary atherosclerosis and development of vulnerable plaque. Curr Opin Cardiol (2000) 1.60
Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med (1975) 1.59
Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem (1989) 1.58
Chewing the fat--how much and what kind? N Engl J Med (1991) 1.57
Ambient particulate air pollution and cardiac arrhythmia in a panel of older adults in Steubenville, Ohio. Occup Environ Med (2006) 1.56
Ischemic, hemodynamic, and neurohormonal responses to mental and exercise stress. Experience from the Psychophysiological Investigations of Myocardial Ischemia Study (PIMI). Circulation (1996) 1.55
Climate change. Uncertainty and climate change assessments. Science (2001) 1.54
Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol (1993) 1.53
A randomized placebo-controlled trial to assess the efficacy of antiinflammatory therapy with methylprednisolone in unstable angina (MUNA trial). Eur Heart J (2000) 1.51
A simplified method to predict occurrence of complete heart block during acute myocardial infarction. Am J Cardiol (1986) 1.50
Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer (1999) 1.50
Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience). Am J Cardiol (2001) 1.49
Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol (1997) 1.49
Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. Am J Cardiol (1995) 1.48
Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase. Virology (1985) 1.44
Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. J Am Coll Cardiol (1994) 1.43
The Michigan Ambulatory Medical Care Survey. Public Health Rep (1977) 1.42
Effects of serum lipid levels on restenosis after coronary angioplasty. Am J Cardiol (1991) 1.41
Determination of blood flow and endothelial shear stress in human coronary artery in vivo. J Invasive Cardiol (1999) 1.41
Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation (1984) 1.41
TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. Circulation (1999) 1.40
The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. J Am Diet Assoc (1999) 1.40
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators. Eur Heart J (2000) 1.40
Blood pressure in vegetarians. Am J Epidemiol (1974) 1.40
Pericarditis in acute myocardial infarction: characterization and clinical significance. Am Heart J (1989) 1.40
The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens (2000) 1.39
Is there anything to add to our lipid risk factors for coronary heart disease? Am J Cardiol (1995) 1.39
Heterogeneity of influenza B viruses. Bull World Health Organ (1983) 1.39
Outcome of patients with acute myocardial infarction who are ineligible for primary angioplasty trials. Catheter Cardiovasc Interv (2000) 1.39
Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II. Eur Heart J (2002) 1.38